Terms: = Thyroid cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Treatment
23 results:
1. TCF12 regulates exosome release from epirubicin-treated CAFs to promote ER+ breast cancer cell chemoresistance.
Qiu Y; Wang X; Sun Y; Du YE; Yin G; Luo H; Wen S; Lang L; Liu M; Tang X
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166727. PubMed ID: 37137433
[TBL] [Abstract] [Full Text] [Related]
2. A Multiple Targeting Nanoprobe for Identifying cancer Metastatic Sites Based on Detection of Various mRNAs in Circulating Tumor Cells.
Han D; Ren XH; Liao XR; He XY; Guo T; Chen XS; Pang X; Cheng SX
Nano Lett; 2023 May; 23(9):3678-3686. PubMed ID: 37052638
[TBL] [Abstract] [Full Text] [Related]
3. Exosomal miR-655-3p inhibits growth, and invasion and macrophage M2 polarization through targeting cxcr4 in papillary thyroid carcinoma.
Qiao L; Dong C; Jia W; Ma B
Acta Biochim Pol; 2022 Dec; 69(4):773-779. PubMed ID: 36512648
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic significance of cxcr4 and SDF-1 in differentiated thyroid cancer depends on CD8+ density.
Wilhelm A; Lemmenmeier I; Lalos A; Posabella A; Kancherla V; Piscuoglio S; Delko T; von Flüe M; Glatz K; Droeser RA
BMC Endocr Disord; 2022 Nov; 22(1):292. PubMed ID: 36419107
[TBL] [Abstract] [Full Text] [Related]
5. Comparative evaluation of somatostatin and cxcr4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies.
Czajkowski M; Kaemmerer D; Sänger J; Sauter G; Wirtz RM; Schulz S; Lupp A
BMC Cancer; 2022 Jul; 22(1):740. PubMed ID: 35799158
[TBL] [Abstract] [Full Text] [Related]
6.
Godugu K; Mousa SA; Glinsky GV; Lin HY; Davis PJ
Front Endocrinol (Lausanne); 2022; 13():745327. PubMed ID: 35311239
[TBL] [Abstract] [Full Text] [Related]
7. Clinical association of cxcr4 in primary tumor of papillary thyroid cancer and response to iodine-131 treatment.
Sirakriengkrai K; Tepmongkol S; Keelawat S; Techavijit U
Nucl Med Commun; 2021 Apr; 42(4):396-401. PubMed ID: 33306632
[TBL] [Abstract] [Full Text] [Related]
8. Chaperone-mediated Autophagy Governs Progression of Papillary thyroid Carcinoma via PPARγ-SDF1/cxcr4 Signaling.
Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
[TBL] [Abstract] [Full Text] [Related]
9. Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges.
Refardt J; Hofland J; Kwadwo A; Nicolas GP; Rottenburger C; Fani M; Wild D; Christ E
Rev Endocr Metab Disord; 2021 Sep; 22(3):581-594. PubMed ID: 32495250
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA‑mRNA integrated analysis based on a case of well‑differentiated thyroid cancer with both metastasis and metastatic recurrence.
Zhang YJ; Ma YS; Xia Q; Yu F; Lv ZW; Jia CY; Jiang XX; Zhang L; Shao YC; Xie WT; Lu GX; Yv XQ; Zhong P; Fu D; Wang XF
Oncol Rep; 2018 Dec; 40(6):3803-3811. PubMed ID: 30272320
[TBL] [Abstract] [Full Text] [Related]
11. Hypofractionated Radiotherapy Is Superior to Conventional Fractionation in an Orthotopic Model of Anaplastic thyroid cancer.
Oweida A; Phan A; Vancourt B; Robin T; Hararah MK; Bhatia S; Milner D; Lennon S; Pike L; Raben D; Haugen B; Pozdeyev N; Schweppe R; Karam SD
Thyroid; 2018 Jun; 28(6):739-747. PubMed ID: 29774792
[TBL] [Abstract] [Full Text] [Related]
12. The CXCL12-cxcr4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
Lin Y; Ma Q; Li L; Wang H
Biochem Cell Biol; 2018 Oct; 96(5):619-626. PubMed ID: 29316404
[TBL] [Abstract] [Full Text] [Related]
13. cxcr4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.
Werner TA; Forster CM; Dizdar L; Verde PE; Raba K; Schott M; Knoefel WT; Krieg A
Br J Cancer; 2017 Dec; 117(12):1837-1845. PubMed ID: 29112684
[TBL] [Abstract] [Full Text] [Related]
14. Estrogen-induced SDF-1α production promotes the progression of ER-negative breast cancer via the accumulation of MDSCs in the tumor microenvironment.
Ouyang L; Chang W; Fang B; Qin J; Qu X; Cheng F
Sci Rep; 2016 Dec; 6():39541. PubMed ID: 27996037
[TBL] [Abstract] [Full Text] [Related]
15. MicroRNA‑126 is downregulated in thyroid cancer cells, and regulates proliferation, migration and invasion by targeting cxcr4.
Qian Y; Wang X; Lv Z; Guo C; Yang Y; Zhang J; Wang X
Mol Med Rep; 2016 Jul; 14(1):453-9. PubMed ID: 27175968
[TBL] [Abstract] [Full Text] [Related]
16. INHIBITORY ACTION OF CoCl2-INDUCED MCF-7 CELL HYPOXIA MODEL OF BREAST cancer AND ITS INFLUENCE ON VASCULAR ENDOTHELIAL GROWTH FACTOR.
Zhang M; Ma R; Li Q
J Biol Regul Homeost Agents; 2015; 29(3):671-6. PubMed ID: 26403405
[TBL] [Abstract] [Full Text] [Related]
17. NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription.
Qin L; Xu Y; Xu Y; Ma G; Liao L; Wu Y; Li Y; Wang X; Wang X; Jiang J; Wang J; Xu J
Oncotarget; 2015 Sep; 6(27):23890-904. PubMed ID: 26287601
[TBL] [Abstract] [Full Text] [Related]
18. Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.
Yun JY; Kim YA; Choe JY; Min H; Lee KS; Jung Y; Oh S; Kim JE
J Clin Pathol; 2014 Feb; 67(2):125-33. PubMed ID: 23986551
[TBL] [Abstract] [Full Text] [Related]
19. Assessment of biomarkers for clinical diagnosis of papillary thyroid carcinoma with distant metastasis.
Liang H; Zhong Y; Luo Z; Huang Y; Lin H; Luo M; Zhan S; Xie K; Ma Y; Li QQ
Int J Biol Markers; 2010; 25(1):38-45. PubMed ID: 20306451
[TBL] [Abstract] [Full Text] [Related]
20. cxcr4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph node metastasis.
Yasuoka H; Kodama R; Hirokawa M; Takamura Y; Miyauchi A; Sanke T; Nakamura Y
BMC Cancer; 2008 Sep; 8():274. PubMed ID: 18826577
[TBL] [Abstract] [Full Text] [Related]
[Next]
